Effects of omalizumab in Aspergillus-associated airway disease
Impacte
Scholar |
Altres documents de l'autoria: Pérez de Llano, L. A.; Vennera, M. C.; Parra, A.; Guallar, J.; Marín, M.; Asensio, O.; Ausin, P.; Borderías, L.; Fernández, C.; Granell, Carlos; Pérez Pimiento, A.; Rubio, M.
Metadades
Mostra el registre complet de l'elementcomunitat-uji-handle:10234/9
comunitat-uji-handle2:10234/36080
comunitat-uji-handle3:10234/36082
comunitat-uji-handle4:
INVESTIGACIONAquest recurs és restringit
http://dx.doi.org/10.1136/thx.2010.153312 |
Metadades
Títol
Effects of omalizumab in Aspergillus-associated airway diseaseAutoria
Data de publicació
2011-03Editor
Georg Thieme VerlagCita bibliogràfica
PÉREZ-DE-LLANO, L. A., et al. Effects of omalizumab in Aspergillus-associated airway disease. Thorax, 2011, vol. 66, no 6, p. 539-540.Tipus de document
info:eu-repo/semantics/articleVersió de l'editorial
http://thorax.bmj.com/content/early/2011/03/10/thx.2010.153312Versió
info:eu-repo/semantics/publishedVersionParaules clau / Matèries
Resum
The clinical spectrum of Aspergillus-associated
airway diseases (AAAD) includes
Aspergillus-induced asthma, allergic bronchopulmonary
aspergillosis (ABPA) and
bronchocentric granulomatosis. Corticosteroids
are ... [+]
The clinical spectrum of Aspergillus-associated
airway diseases (AAAD) includes
Aspergillus-induced asthma, allergic bronchopulmonary
aspergillosis (ABPA) and
bronchocentric granulomatosis. Corticosteroids
are almost always used to suppress the
immunological response to the fungal antigens.1
Although there are no evidence-based
alternative treatment options besides
steroids, the well-known adverse effects of
these drugs have prompted clinicians to look
beyond this standard practice and several
cases of ABPA patients with very positive
outcomes after omalizumab therapy have
been recently published. [-]
Publicat a
Thorax, 2011, vol. 66, no 6Drets d'accés
http://rightsstatements.org/vocab/CNE/1.0/
info:eu-repo/semantics/restrictedAccess
info:eu-repo/semantics/restrictedAccess
Apareix a les col.leccions
- MED_Articles [632]